Across TCGA pan-cancer cohorts, MIR1-1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of MIR1-1’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR1-1 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR1-1 is over-expressed in tumor, although a few such as HNSC show the opposite, repressed pattern.
HNSC are the cancer types where MIR1-1 tumor–normal differential expression is most reproducible.